Orgenesis to Participate in Benchmark's 3rd Annual
GERMANTOWN, Md., May 19, 2023 (GLOBE NEWSWIRE) -- Orgenesis Inc. (NASDAQ: ORGS) (“Orgenesis” or the “Company”), a global biotech company working to...
Source: globenewswire.com
Page 7 - Ib Communications News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Ib Communications. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Ib Communications Today - Breaking & Trending Today
BioSenic reacquires global IP rights and provides update on JTA-004 development
INSIDE INFORMATION BioSenic plans to further develop its program on an active injectable viscosupplement JTA, combining anti-pain and anti-inflammatory characteristics on a subtype of knee... | May 17, 2023
Source: marketscreener.com
BioSenic to host Annual General Meeting on June 14 2023
REGULATED INFORMATION Preliminary documents for the Annual General Meeting have been made available on company’s website Mont-Saint-Guibert, Belgium, May 15th, 2023 7.00am CET –... | May 15, 2023
Source: marketscreener.com
BioSenic receives key European patent from EPO, for further therapeutic development in cancer, infectious and immune diseases
INSIDE INFORMATION Patent covers the therapeutic use of a new composite formulation of anti-inflammatory compounds with unique advantages BioSenic’s new formulation lowers the dosage of... | April 18, 2023
Source: marketscreener.com
BioSenic provides Financial Update and Financial Calendar 2023
INSIDE INFORMATION Mont-Saint-Guibert, Belgium, March 31, 2023, 7am CET - BIOSENIC (Euronext Brussels and Paris: BIOS), the clinical stage company specializing in severe autoimmune/inflammatory diseases
Source: finanznachrichten.de